ADAR1 Capital Management, LLC
Q4 2025 13F Holdings
- Locationaustin, TX
- Num holdings
270
- Value ($000)
$1,361,602
- Date Filed02/18/2026
- Form typerestatement
- CIK0001940272
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 00370M103 | $177.65M | 13 % | 1,317,329 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $91.63M | 7 % | 1,049,168 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | $74.41M | 6 % | 3,428,962 | ||
IMMUNOVANT INC | COM | 45258J102 | $63.07M | 5 % | 2,480,968 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | $39.42M | 3 % | 546,534 | ||
EA SERIES TRUST | ALPHA ARCH 1-3 | 02072L565 | $38.8M | 3 % | 337,125 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $37.29M | 3 % | 54,684 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | $34.32M | 3 % | 540,166 | ||
SEPTERNA INC | COM | 81734D104 | $32.27M | 2 % | 1,157,611 | ||
ARBUTUS BIOPHARMA CORP | COM | 03879J100 | $26.05M | 2 % | 5,415,109 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100